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Complementary and alternative drugs (CADs) are widely used in preoperative patients and may lead to potential interactions and
adverse reactions. The aim of our study is to evaluate the prevalence and the predictors of CADs use among preoperative patients
using data from an Italian survey. This cross-sectional study, which enrolled 478 patients (response rate: 83.5%), was carried out
in three Tuscany hospitals (Italy). The prevalence of CADs use was 49.8%: 233 out of 238 participants used herbal products and/or
dietary supplements. Valeriana oﬃcinalis was the most reported product (19.4%). According to univariate analysis, users were
commonly identiﬁed among middle-aged or older patients; unadjusted ORs were 2.1 (95% CI: 1.3–3.3) for patients aged 48–69
years, and 3.0 (95% CI: 1.9–4.7) for those of 70–95 years, when compared with individuals aged 18–47 years. Except for education
and gender, adjusted estimates showed consistent results with univariate analyses: direct association was observed with higher
education, and—although not signiﬁcantly—with female gender. The high prevalence of CAD use in preoperative period could
be suggestive of a certain risk of adverse eﬀects due to CADs interactions. A careful medical history of CADs consumption should
be ascertained before surgery.
1.Introduction
The use of herbal drugs and other alternative medications is
widespread across Western countries [1–3]. In Italy, 13.6%
of the Italian population (about 8 million people) reported
the use of nonconventional therapies, and 3.7% of herbal
remedies. The latter percentage reached 4.3 in Tuscany [4].
Users of complementary and alternative drugs (CADs)
consider these remedies safe because “natural” [5]. Nev-
ertheless, several epidemiological studies and case reports
underlined the risk of adverse events associated with their
consumption, and in some clinical settings, the use of
alternative medications can be particularly dangerous [6,
7]. Anaesthesia often involves the administration of drugs
belonging to diﬀerent classes, and patients are usually
under pharmacological treatment because of their surgical
condition or for other comorbidities [8].2 Evidence-Based Complementary and Alternative Medicine
Many studies have been conducted in order to evaluate
the prevalence of CADs use in preoperative period [9–
19]. The highest prevalence of CADs use was found in a
cohort study conducted in Hong Kong (China) [19]o n
601 patients undergoing surgery: 80% of them took self-
prescribed traditional Chinese herbal medicines, and 8%
used them within the two weeks before surgery. The lowest
p r e v a l e n c ew a sr e p o r t e di nas u r v e yc o n d u c t e di naU K
hospitalsetting[14]on2723patients:4.8%ofthemtookone
or more herbal medications. Other surveys were conducted
in USA [9–13, 16, 20], in Europe [17, 18], and Canada
[15, 21]. To our knowledge, no studies on adult patients in
preoperative period have been conducted in Italy.
Although there is no deﬁnite evidence, the complications
that could arise from commonly used herbal medications
include myocardial infarction, stroke, bleeding, inadequate
oral anticoagulation, prolonged eﬀects of anaesthesia, organ
transplant rejection, and potential interactions with con-
ventional pharmacotherapy [22]. Given these potentially
serious complications, and the lack of Italian data on this
topic, the prevalence and the predictors of CADs use among
preoperative patients were investigated by conducting a
cross-sectional survey of patients at the time of presurgical
anaesthesiological visit.
2. Methods
ThissurveywasconductedfromNovember2007toFebruary
2008, in three hospitals of Tuscany (Italy): Empoli, Florence,
and Prato, after institutional authorization. The sample pop-
ulationconsistedofpatientsadmittedtothehospitalinorder
to undergo a surgical intervention, at time of their preop-
erative evaluation (before surgery): thus, recall bias should
be strongly reduced. All eligible participants, consecutively
recruited, received written and oral information about the
study, and written informed consent was obtained.
Data were collected by means of a semistructured ques-
tionnaireadministeredbyatrainednurseusingaface-to-face
interview.
The questionnaire included socio-demographic charac-
teristics (age, gender, education, and occupation), clinical
information (chronic current diseases and the operative class
risk score according to American Society of Anaesthesiol-
ogists (ASA) physical status classiﬁcation), use of synthetic
drugs and CADs in the latter two weeks before interview
(information on name, number of medications, and the
reason of use was collected). Before each interview, patients
received a deﬁnition of CADs, generally deﬁned as “any type
of product manufactured from plant or with natural origin.”
Any series of items was combined according to the
methodological literature [23–27], and it was validated by an
ad hoc panel of experts (pharmacologists, epidemiologists,
toxicologists, pharmacists, and clinicians) of the Tuscan
Regional Centre of Pharmacovigilance, a clinician of the
regional referring Centre of Natural Medicine, and a group
of clinicians and nurses of the three hospitals.
In order to determine the predictors of CADs use,
odds ratios (ORs) and the corresponding 95% conﬁdence
Table 1:Characteristicsof478patientsattimeoftheirpreoperative
visit according to general information and use of CADs.
Characteristics No. (%)
Age (years)
18–47 165 (34.5)
48–69 158 (33.1)
70–95 155 (32.4)
Sex
Male 202 (42.3)
Female 276 (57.7)
Education (degree)
Primary school 160 (33.5)
Secondary school 128 (26.8)
High school 150 (31.4)
University 40 (8.4)
Occupation
Homemaker 159 (33.3)
Retired 81 (17.0)
Labourer 75 (15.7)
Oﬃce worker 70 (14.6)
Merchant 66 (13.8)
Others 27 (5.6)
ASA physical status classiﬁcation
1 179 (37.5)
2 233 (48.7)
≥3 66 (13.8)
Number of conventional medications
0 171 (35.8)
1-2 160 (33.5)
≥3 147 (30.7)
Use of CADs
No 240 (50.2)
Yes 238 (49.8)
CADs: complementary and alternative drugs.
ASA: American Society of Anaesthesiologists.
intervals (CIs) were estimated using univariate and multi-
variatelogisticregressionmodels.Eachvariablecollectedwas
evaluated as a predictor or protective factor whether it was
related to a 10% increase or decrease of univariate OR [28].
Subsequently, it was retained in the ﬁnal models according to
Likelihood Ratio Test. A P-value below 0.05 was considered
an index of statistical signiﬁcance.
Data management and statistical analysis were per-
formedusingSPSS14.0forWindows(SPSSInc,Chicago,Ill)
and Stata 10.0 (College Station, Tex), respectively.
3. Results
Five hundred seventy-two patients were enrolled at time of
their preoperative visit: ninety-ﬁve of them(16.5%) were not
able to report essential information. Thus, the analysis was
restricted to 478 subjects.Evidence-Based Complementary and Alternative Medicine 3
Table 1 shows the characteristics of 478 enrolled patients
according to selected covariates and CADs use. Patients were
mainly female (57.7%), with a low-education level (33.5%
with primary school degree compared to 8.4% with uni-
versity one). A high percentage (33.3%) were homemakers.
One-hundred seventy-nine (37.5%) patients were in the ﬁrst
category of ASA physical status classiﬁcation, 233 (48.7%)
in the second one, and 66 (13.8%) in the third category.
Only one patient was in the fourth category, so he was
grouped with the third level. Three-hundred patients (65%)
used more than one conventional drug, and 147 (30.7%)
used more than three. Overall, the prevalence of CADs use
was 49.8%, and 233 out of 238 used herbal products and/or
dietary supplements.
Among 238 CADs users, drugs mainly reported were
Valeriana oﬃcinalis (19.4%), Matricaria recutita (8.7%),
Vaccinium myrtillus (7.8%), Aloe vera (6.8%), and Echinacea
purpurea (6.8%). Other type of CADs used were Tarax-
acum oﬃcinale (5.8%), Harpagophytum procumbens (4.8%),
Crataegus oxyacantha, Panax ginseng, Soy isoﬂavones, and
Ribes nigrum (3.9%) (Figure 1).
3.1. Statistical Analysis. Table 2 gives the unadjusted ORs
and the corresponding 95% CI for 238 users and 240
nonusers of CADs according to age, gender, and other
selected characteristics. Advanced age was directly associated
to the use of CADs: compared to patients of 18–47 years,
the OR were 2.1 (95% CI: 1.3–3.3) for patients of 48–69
years and 3.0 (95% CI: 1.9–4.7) for those of 70–95 years.
Direct associations were also found among retired patients
compared to homemakers (OR = 3.2; 95% CI: 1.7–5.7)
and for users of more than three conventional drugs when
compared with nonusers (OR = 2.1; 95% CI: 1.4–3.4).
With a borderline signiﬁcance, the highest category of ASA
physical status classiﬁcation was directly related to the use
(OR 1.8, 95% CI: 1.0–3.2, in patients in the third or higher
category towards the lowest one). No signiﬁcant associations
emerged between use of CADs and gender or education.
According to Likelihood Ratio Test, mutual adjustment
for age, gender, education, and occupation did not substan-
tially change the univariate estimates, except for education:
the ORs were 2.6 (95% CI: 1.4–4.7) and 3.5 (95% CI: 1.5–
8.3) for subjects with high school degree and university
degree, respectively (Table 3). Moreover, the use was higher
in females than in males, although the association was not
signiﬁcant.
When homeopathic medications were excluded, the ORs
did not substantially change and the predictors of use were
the same observed for CADs use (data not shown).
4. Discussion
Our study reveals that 49.8% of 478 patients undergoing
a presurgical anaesthesiological examination used an alter-
native medication. They were commonly identiﬁed among
middle-aged and older, retired, with a high educational level,
taking more than one conventional drug, and characterized
by a higher ASA physical status classiﬁcation. Moreover,
Table 2: Unadjusted odds ratiosa (ORs) and corresponding 95%
conﬁdence intervals (CI) for 238 users and 240 nonusers of CADs
according to selected covariates.
Characteristics
CADs use -no. (%)
OR (95% CI)
Yes No
Age (years)
18–47 58 (24.4) 107 (44.6) 1b
48–69 84 (35.3) 74 (30.8) 2.1 (1.3–3.3)
70–95 96 (40.3) 59 (24.6) 3.0 (1.9–4.7)
Sex
Male 94 (39.5) 108 (45) 1b
Female 144 (60.5) 132 (55) 1.2 (0.8–1.8)
Education (degree)
Primary school 81 (34.0) 79 (32.9) 1b
Secondary school 51 (21.4) 77 (32.0) 0.6 (0.4–1.0)
High school 80 (33.6) 70 (29.2) 1.1 (0.7–1.7)
University 26 (10.9) 14 (5.8) 1.8 (0.9–3.7)
Occupation
Homemaker 26 (10.9) 40 (16.7) 1b
Retired 107 (45.0) 52 (21.7) 3.2 (1.7–5.7)
Labourer 25 (10.5) 56 (23.3) 0.7 (0.3–1.4)
Oﬃce worker 30 (12.6) 45 (18.7) 1.0 (0.5–2.0)
Merchant 16 (6.7) 11 (4.6) 2.2 (0.9–5.6)
Others 34 (14.3) 36 (15.0) 1.5 (0.7–2.9)
ASA physical status
classiﬁcation
1 76 (31.9) 103 (42.9) 1b
2 124 (52.1) 109 (45.4) 1.5 (1.0–2.3)
≥3 38 (16.0) 28 (11.7) 1.8 (1.0–3.2)
Number of conventional
medications
0 69 (29.0) 102 (42.5) 1b
1-2 82 (34.5) 78 (32.5) 1.5 (1.0–2.4)
≥3 87 (36.5) 60 (25.0) 2.1 (1.4–3.4)
aEstimates from logistic regression models.
bReference category.
CADs: complementary and alternative drugs.
ASA: American Society of Anaesthesiologists.
although not signiﬁcantly, the risk of CADs use was higher
among females than males.
Compared to other European studies, the prevalence of
use observed in our survey was higher than those reported
in a British survey including 2723 patients (4.8% used one
or more herbal remedies) [14], as well as in a French
multicenter study including 1057 patients (9% used one
or more herbal remedies) [17]. In contrast, our estimated
prevalence was lower than that reported in a northeast
Scottish cross-sectional survey including 285 subjects (63%
used complementary and alternative medicine) [18].
Compared to non-European countries, one study from
China [19] reported higher prevalence, while ﬁve studies
from the USA [10, 11, 13, 16, 20] and two from Canada
[15, 21]r e p o r t e dl o w e rp r e v a l e n c e .I nas t u d yc a r r i e do u ti n4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Percentages of 238 CADs users who consumed various CADs. CADs: complementary and alternative drugs.
Table 3: Adjusted odds ratiosa (ORs) and corresponding 95%
conﬁdence intervals (CI) for 238 users and 240 nonusers of CADs
according to selected covariates.
Characteristics OR (95% CI)
Sex
Male 1b
Female 1.4 (0.9–2.1)
Education (degree)
Primary school 1b
Secondary school 1.2 (0.7–2.0)
High school 2.6 (1.4–4.7)
University 3.5 (1.5–8.3)
Occupation
Homemaker 1b
Retired 2.3 (1.1–4.5)
Labourer 0.9 (0.4–1.8)
Oﬃce worker 0.8 (0.4–1.8)
Merchant 2.7 (1.0–7.1)
Others 1.3 (0.6–2.8)
aEstimates from logistic regression models adjusted for age, gender,
education, and occupation.
bReference category.
CADs: complementary and alternative drugs.
USA [12], 12.9% of middle-aged and older cardiac patients
conﬁrmed vitamin use, 11.6% herbs and folk remedies use,
and 3.6% use of homeopathy. In another American survey
[9] of patients undergoing cardiac surgery, 53.6% used
vitamins, 17.1% nutritional therapy, 9.9% herbs, and 3.0%
homeopathy. Such ﬁndings variability could be explained
by the deﬁnition of complementary medicine itself [29].
In fact, our survey was aimed at exploring the use of
any so-called “products manufactured from herbs and/or
with natural origin” and was focused on remedies that
did not include, for example, acupuncture or meditation
but only pharmacological-like treatment. For this reason
the overall prevalence was higher or lower when compared
with that reported in other investigations. In particular, our
deﬁnition was less or more restrictive when compared to
those European surveys which showed, respectively, a lower
or a higher prevalence of CAD use [14, 17, 18].
As far as predictors of use are concerned, our results
are in agreement with other studies that reported direct
association between CADs use and older age [10, 11, 14,
16, 17], higher education [11], and female gender [10, 11,
14–17]. The fact that advanced age and use of concurrent
conventional medications were predictors of CADs use may
be due to the burden of comorbidity in older subjects
[30, 31]. Indeed, although with a minor impact on the
clinical condition, use of CADs with a sedative action or
anti-inﬂammatory properties could be adopted for more
common diseases and/or their symptoms among frail older
patients [30]. Also, it may be likely explained by the direct
association here reported between CADs use and patients
with a high ASA physical status classiﬁcation—as an index
of more complicated patients. Moreover, patients who have a
bettereducation[32]asw ellasw o me n[33]mayhavegreater
access to healthcare information. This not necessarily means,
however, that women are able to correctly classify eﬃcacy
and safety of this kind of therapy [5].
Generally, in Italy, CADs do not always undergo to
the same regulations as conventional medicine, and there
is often little concern over purity, safety, or teratogenicity
of this kind of medications [5]. Thus, from a clinical
viewpoint, both herbal medications per se as well as their
interaction with conventional drugs may cause clinical
complications during surgical procedures, or the preop-
erative period [22, 34]. In our study, valerian (Valeriana
oﬃcinalis) was most commonly used (19.4%). As shown
in animal studies, this plant is able to induce sedation by
modulating gamma aminobutyric acid neurotransmission.
Theoretically, additive CNS and respiratory depression may
occur when valerian is used concomitantly with opioid
analgesics therefore caution is advised whenever valerian
and an opiate are used in combination [35]. Additionally,
valerian may increase the sedative eﬀects of anaestheticsEvidence-Based Complementary and Alternative Medicine 5
through a synergistic action [22]; thus it should not be
combined with benzodiazepines and barbiturates [36, 37].
Accordingly, a recent study reported that animals given a
combination of midazolam and valerian took signiﬁcantly
longer to emerge from anaesthesia compared with those
treated only with midazolam [38].
Eight point seven % of subjects reported the use cham-
omile (Matricaria recutita). Chamomile contains several
ﬂavonoids, comprising apigenin, which has benzodiazepine-
agonist and histamine-antagonist eﬀects [39, 40], and tan-
nin, which may inhibit iron absorption [34]. Interactions
between Matricaria recutita and opioid analgesics and war-
farin have been reported [35, 41]. Use of blueberry (Vaccini-
um myrtillus), aloe (Aloe vera), and Echinacea (Echinacea
purpurea) were also reported. Blueberry juice contains
ﬂavonoids that may inhibit CYP enzymes, so aﬀecting the
metabolism of warfarin [42, 43]. Also ingestion of aloe can
enhance the hypoglycaemic eﬀect of glibenclamide [44], and
important interactions were also reported between aloe and
sevoﬂurane [45]. Echinacea, itself, showed some hepatotoxic
potential and therefore it should not be taken together
with potentially hepatotoxic drugs, in particular as a self-
medication [34, 35, 46], as well as with midazolam [47].
Our study had several limitations. First, the question-
naire relied on self-reporting information; thus our results
may under- or overestimate the actual prevalence of CADs
use. In addition, no information on dosages was recorded.
Finally, it was not possible to assess any clinical outcome.
These limitations notwithstanding, our study raised several
concerns about the potential risks of anaesthesiological and
surgical procedures in patients exposed to CADs during the
preoperative period. All the aspects here described might
pose patients at risk especially when they belong to an
advanced age group, and concurrent diseases and medica-
tions are present.
In conclusion, although other studies are necessary to
conﬁrmthe clinical burden of our ﬁndings, anaesthetists and
surgeons should be aware of the possible complications due
to the use of CADs. A careful medical history of CAD use
should be taken in patients (especially older and educated
patients) before surgery.
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